<DOC>
	<DOCNO>NCT02903030</DOCNO>
	<brief_summary>The physical mental/emotional health people autism spectrum disorder ( ASD ) closely connect . The emerge data immune abnormality gut microbiome difference , interaction genome suggest possible etiological link physical mental dysfunction , especially gastrointestinal ( GI ) dysfunction severe anxiety many individual ASD manifest . The investigator preliminary clinical evidence child ASD &amp; GI symptom differ microbiome composition function neurotypical child GI symptom . The investigator hypothesize altered host-microbial signal , include altered fecal neurotransmitter gamma-aminobutyric acid ( GABA ) level contribute towards anxiety sensory over-responsivity ASD . Our preliminary finding also show probiotic Visbiome Extra Strength , improve GI pain symptom , correlate alter gut microbiome composition relate metabolite ( macrobiome ) . The propose crossover trial explore possibility new appreciation microbiome-mental/physical function connection ASD , GI dysfunction , anxiety . If alter gut microbiome result well GI emotional function , could improve quality life child ASD parent . A pilot trial 12 child ASD test feasibility propose three-site crossover randomize clinical trial ( RCT ) probiotic ( beneficial bacteria include Lactobacilli &amp; Bifidobacteria ) 60 child 3-12 year old ASD , GI dysfunction , &amp; anxiety . In balanced crossover child randomize 1 ; 1 Visbiome placebo first , 8 week per condition 3 week washout . The investigator access significant fecal microbiome metabolome data NIH-funded Human Microbiome Projects ( HMP ) similar-age healthy irritable-bowel child , without ASD . These help leverage understanding macrobiome change correlate functional improvement GI abdominal pain symptom . Pilot study efficiency also benefit HMPs already collect analyzed baseline stool child ASD , thus save significant cost baseline stool analysis pilot .</brief_summary>
	<brief_title>Probiotics Quality Life Autism Spectrum Disorders</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Autistic Disorder</mesh_term>
	<mesh_term>Autism Spectrum Disorder</mesh_term>
	<mesh_term>Child Development Disorders , Pervasive</mesh_term>
	<mesh_term>Silicon</mesh_term>
	<criteria>1. DSM5 ASD clinical evaluation doctorallevel diagnostician , confirm Autism Diagnostic InterviewRevised Autism Diagnostic Observation Schedule ; 2. 3 12 year old ; 3. &gt; 2 mo . abdominal pain , constipation , diarrhea , and/or vomiting , itemmean score &gt; 2 least one scale GI module PedsQL scale ; 4. clinical anxiety symptom item mean &gt; 1.0 ( 03 scale ) new Autism Anxiety Scale . Participants recruited minority , poor , inner city , rural population . 1 . Antibiotics 2 month prior enrol ; 2 . Prior bowel surgery ; 3 . Chronic serious medical condition ( e.g. , diabetes ) ; 4 . Weight height &lt; 3rd % ile age ; 5 . Chronic antiinflammatory use within 2 month prior enrol ; 6 . History inflammatory bowel disease , Celiac disease , eosinophilic disorder ( e.g. , eosinophilic esophagitis ) ; 7 . Already take probiotic within previous 6 month .</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Gastrointestinal Microbiome</keyword>
</DOC>